Actively Recruiting
Screening of Valvular Heart Disease Using Single-channel Electrocardiogram
Led by I.M. Sechenov First Moscow State Medical University · Updated on 2025-08-01
1200
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
It is a prospective, controlled, single-center, observational, non-randomized study. The study is planned to include at least 1000 patients over 18 years old in the training sample and 200 patients over 18 years old in the test sample (the total number of patients is at least 1200 people). All patients will undergo an echocardiography examination with a comprehensive analysis of the function of the valves and other structures of the heart according to current recommendations by two independent experts. Registration of electrocardiogram will be performed immediately after echocardiography using a single lead ECG monitor (in I standard lead) for 1 minutes. The obtained data will be stored in the remote monitoring center of Sechenov University without being linked to the personal data of patients. A spectral analysis of the electrocardiogram will be performed using a continuous wavelet transform. The result of this study will be the identification of ECG parameters that will correlate with valvular heart disease.
CONDITIONS
Official Title
Screening of Valvular Heart Disease Using Single-channel Electrocardiogram
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Written informed consent to participate in the study
- Age 18 years or older
- Receiving outpatient treatment or hospitalized at the research center
You will not qualify if you...
- Patient unwilling to participate in the study
- Poor quality ECG recording on the single-channel ECG monitor
- Poor heart visualization during echocardiography
- Acute psychotic reactions during the study
- Exacerbation of chronic diseases preventing further study participation
- Conditions impairing ECG quality such as Parkinson's disease or essential tremor
- Mental illness
- Presence of a pacemaker
- Presence of prosthetic heart valves
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Moscow, Russia, 119048
Actively Recruiting
Research Team
N
Natalia Kuznetsova, Dr.
CONTACT
P
Petr Chomakhidze, Prof.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here